Audrey Greenberg turns moonshot ideas into market-shaping companies. An award-winning biotech executive and company builder, she scales ventures at the intersection of science, capital, and impact. As a Mayo Venture Partner, Audrey leads enterprise-wide efforts in venture creation, capital strategy, and commercialization of transformative science. Previously, she co-founded the Center for Breakthrough Medicines and led its acquisition by SK pharmteco. A Wharton MBA and CPA, she serves on multiple boards advancing women’s leadership and healthcare innovation. Recognitions include Endpoints Top Biopharma Executive, Medicine Maker Power List, Titan 100 Hall of Fame, and Healthcare Power Player.

Currently leading strategic venture initiatives that bridge Mayo Clinic innovation with commercial partners, accelerating the creation of new companies at the intersection of biotech, AI, and patient care.